These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 2510643

  • 1. [Protective action of cicletanine on the vascular walls in stroke-prone spontaneously hypertensive rats].
    Ruchoux MM, Droy-Lefaix MT, Bakri F, Berthet P, Bosquet D, Lhuintre Y.
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1163-8. PubMed ID: 2510643
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Malignant hypertensive retinopathy in spontaneously hypertensive stroke-prone rats. Effect of treatment with cicletanine].
    Ruchoux MM, Droy-Lefaix MT, Bakri F, Berthet P, Bosquet D, Lhuintre Y.
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1281-4. PubMed ID: 2510662
    [Abstract] [Full Text] [Related]

  • 4. The effect of cicletanine on cerebrovascular injury in stroke-prone spontaneously hypertensive rats.
    Ruchoux MM, Huguet F, Droy-Lefaix MT, Gelot A, Ruchoux P, Autret A.
    Am J Hypertens; 1989 Sep; 2(9):683-9. PubMed ID: 2803675
    [Abstract] [Full Text] [Related]

  • 5. [Effectiveness of cicletanine on lesions in spontaneously hypertensive rats. Curative study--dose-effect relationship].
    Droy-Lefaix MT, Ruchoux MM, Berthet P, Bakri F, Bosquet D, Narcisse G, Guillemain G.
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():163-8. PubMed ID: 2514659
    [Abstract] [Full Text] [Related]

  • 6. [Protective effect of cicletanine in hypertensive retinopathy. Evaluation of retinal function in the isolated retina].
    Millerin M, Doly M, Betin C, Malherbe E, Droy MT, Braquet P.
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():175-9. PubMed ID: 2514661
    [Abstract] [Full Text] [Related]

  • 7. Cicletanine and hypertensive retinopathy.
    Ruchoux MM, Droy-Lefaix MT, Bakri F, Guillemain J, Ruchoux P, Autret A.
    Ophthalmic Res; 1990 Nov; 22(5):318-29. PubMed ID: 2090985
    [Abstract] [Full Text] [Related]

  • 8. [Effects of treatment with cicletanine on kidney PGE2 and PGI1 in spontaneously hypertensive rats].
    Deby C, Deby-Dupont G, Droy-Lefaix MT, Bosquet D, Berthet P, Bakri F.
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():37-40. PubMed ID: 2514666
    [Abstract] [Full Text] [Related]

  • 9. [Cicletanine avoids the proliferation of vascular smooth muscle in the spontaneously hypertensive rat].
    Bukoski RD.
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1313-6. PubMed ID: 2124474
    [Abstract] [Full Text] [Related]

  • 10. In vivo and in vitro effects of cicletanine in spontaneously hypertensive rats.
    Auguet M, Guillon JM, Delaflotte S, Le Hegarat M, Pirotzky E, Clostre F, Braquet P.
    Drugs Exp Clin Res; 1988 Jul; 14(2-3):89-95. PubMed ID: 3416727
    [Abstract] [Full Text] [Related]

  • 11. Vascular actions of cicletanine.
    Bukoski RD, Wagman DW, de Wan P, Xue H.
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():45-50. PubMed ID: 2514668
    [Abstract] [Full Text] [Related]

  • 12. [Effect of cicletanine on the mechanical properties of the arterial wall].
    Levy BI, Poitevin P, Safar ME.
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():67-70. PubMed ID: 2514672
    [Abstract] [Full Text] [Related]

  • 13. The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats.
    Rakusan K, Cicutti N, Maurin A, Guez D, Schiavi P.
    Microvasc Res; 2000 Mar; 59(2):243-54. PubMed ID: 10684730
    [Abstract] [Full Text] [Related]

  • 14. Protective effect of cicletanine on renal function in diabetic spontaneously hypertensive rats.
    Duran MJ, Sennoune S, Arnaud C, Garcia S, Droy-Lefaix MT, Maixent JM.
    Cell Mol Biol (Noisy-le-grand); 2004 Nov; 50(7):869-74. PubMed ID: 15672472
    [Abstract] [Full Text] [Related]

  • 15. General pharmacology of cicletanine.
    Clostre F, Etienne A.
    Drugs Exp Clin Res; 1988 Nov; 14(2-3):73-82. PubMed ID: 3416726
    [Abstract] [Full Text] [Related]

  • 16. Comparison of cicletanine with other antihypertensive drugs in SHR-SP models.
    Malherbe E, Le Hegarat M, Clostre F, Braquet P.
    Drugs Exp Clin Res; 1988 Nov; 14(2-3):83-8. PubMed ID: 2970955
    [Abstract] [Full Text] [Related]

  • 17. Antiproliferative and endothelium-dependent vasodilator properties of 1,3-dihydro-3-p-chlorophenyl-7-hydroxy-6-methyl-furo-(3,4c) pyridine hydrochloride (cicletanine).
    Bukoski RD, Bo J, Xue H, Bian K.
    J Pharmacol Exp Ther; 1993 Apr; 265(1):30-5. PubMed ID: 8474013
    [Abstract] [Full Text] [Related]

  • 18. Changes in the composition of the thoracic aortic wall in spontaneously hypertensive rats treated with losartan or spironolactone.
    Han WQ, Wu LY, Zhou HY, Zhang J, Che ZQ, Wu YJ, Liu JJ, Zhu DL, Gao PJ.
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):583-8. PubMed ID: 19673944
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of cilazapril on the cerebral circulation.
    Véniant M, Clozel JP, Kuhn H, Clozel M.
    J Cardiovasc Pharmacol; 1993 May; 22 Suppl 1():S30-5. PubMed ID: 7507537
    [Abstract] [Full Text] [Related]

  • 20. Chronic treatment of DA-8159, a new phosphodiesterase type V inhibitor, attenuates endothelial dysfunction in stroke-prone spontaneously hypertensive rat.
    Choi SM, Kim JE, Kang KK.
    Life Sci; 2006 Feb 09; 78(11):1211-6. PubMed ID: 16214180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.